Shed syndecan-1 inhibits myeloma cell growth: A mechanism of autocrine growth control in multiple myeloma.

被引：0
|
作者：
Dhodapkar, M
Theus, A
Langford, K
Butch, A
Barlogie, B
Sanderson, R
机构：
[1] UNIV ARKANSAS,LITTLE ROCK,AR 72204
[2] VAMC,LITTLE ROCK,AR
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [21] Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
    Lamorte, S.
    Ferrero, S.
    Aschero, S.
    Monitillo, L.
    Bussolati, B.
    Omede, P.
    Ladetto, M.
    Camussi, G.
    LEUKEMIA, 2012, 26 (05) : 1081 - 1090
  • [22] Serum syndecan-1: a new independent prognostic marker in multiple myeloma
    Seidel, C
    Sundan, A
    Hjorth, M
    Turesson, I
    Dahl, IMS
    Abildgaard, N
    Waage, A
    Borset, M
    BLOOD, 2000, 95 (02) : 388 - 392
  • [23] Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
    S Lamorte
    S Ferrero
    S Aschero
    L Monitillo
    B Bussolati
    P Omedè
    M Ladetto
    G Camussi
    Leukemia, 2012, 26 : 1081 - 1090
  • [24] Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma
    Jánosi, J
    Sebestyén, A
    Mikala, G
    Németh, J
    Kiss, Z
    Vályi-Nagy, I
    HAEMATOLOGICA, 2004, 89 (03) : 370 - 371
  • [25] Vascular endothelial growth factor and angiogenesis multiple myeloma.
    Sjak-Shie, NN
    Sulur, GG
    Said, JW
    Schrage, M
    Vescio, RA
    Berenson, JR
    BLOOD, 1999, 94 (10) : 305B - 305B
  • [26] Serum transforming growth factor beta 1 levels in multiple myeloma.
    Coskun, HS
    Ilhan, O
    Özcan, M
    Ayaz, S
    Dalva, K
    Üstün, C
    Arat, M
    Beksaç, M
    BLOOD, 1998, 92 (10) : 262B - 262B
  • [27] SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
    Ritchie, Joseph P.
    Ramani, Vishnu C.
    Ren, Yongsheng
    Naggi, Annamaria
    Torri, Giangiacomo
    Casu, Benito
    Penco, Sergio
    Pisano, Claudio
    Carminati, Paolo
    Tortoreto, Monica
    Zunino, Franco
    Vlodavsky, Israel
    Sanderson, Ralph D.
    Yang, Yang
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1382 - 1393
  • [28] Role of HIF as a growth and survival factor in multiple myeloma.
    Feinman, R
    Abungu, B
    Barlos, D
    BLOOD, 2005, 106 (11) : 954A - 954A
  • [29] Targeting myeloma cell growth factors in multiple myeloma
    Klein, B.
    Hose, D.
    Moreaux, J.
    De Vos, J.
    Jourdan, M.
    Sprinsky, A. C.
    Jourdan, E.
    Reme, T.
    Mahtouk, K.
    Goldschmidt, H.
    Rossi, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 43 - 44
  • [30] Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis
    Andersen, Niels F.
    Kristensen, Ida B.
    Preiss, Birgitte S.
    Christensen, Jacob H.
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 211 - 217
12345